Thyroid surgery for differentiated thyroid cancer—recent advances and future directions
Population-based studies have demonstrated that an increasing number of incidental
thyroid nodules are being identified. The corresponding increase in thyroid-based …
thyroid nodules are being identified. The corresponding increase in thyroid-based …
Thyroseq v3, Afirma GSC, and microRNA panels versus previous molecular tests in the preoperative diagnosis of indeterminate thyroid nodules: a systematic review …
CA Silaghi, V Lozovanu, CE Georgescu… - Frontiers in …, 2021 - frontiersin.org
Background Molecular tests are being used increasingly as an auxiliary diagnostic tool so
as to avoid a diagnostic surgery approach for cytologically indeterminate thyroid nodules …
as to avoid a diagnostic surgery approach for cytologically indeterminate thyroid nodules …
The American Association of Endocrine Surgeons guidelines for the definitive surgical management of thyroid disease in adults
KN Patel, L Yip, CC Lubitz, EG Grubbs, BS Miller… - Annals of …, 2020 - journals.lww.com
Objective: To develop evidence-based recommendations for safe, effective, and appropriate
thyroidectomy. Background: Surgical management of thyroid disease has evolved …
thyroidectomy. Background: Surgical management of thyroid disease has evolved …
Performance of a multigene genomic classifier in thyroid nodules with indeterminate cytology: a prospective blinded multicenter study
DL Steward, SE Carty, RS Sippel, SP Yang… - JAMA …, 2019 - jamanetwork.com
Importance Approximately 20% of fine-needle aspirations (FNA) of thyroid nodules have
indeterminate cytology, most frequently Bethesda category III or IV. Diagnostic surgeries can …
indeterminate cytology, most frequently Bethesda category III or IV. Diagnostic surgeries can …
NCCN guidelines insights: thyroid carcinoma, version 2.2018
RI Haddad, C Nasr, L Bischoff, NL Busaidy… - Journal of the National …, 2018 - jnccn.org
The NCCN Guidelines for Thyroid Carcinoma provide recommendations for the
management of different types of thyroid carcinoma, including papillary, follicular, Hürthle …
management of different types of thyroid carcinoma, including papillary, follicular, Hürthle …
Thyroid nodules: diagnostic evaluation based on thyroid cancer risk assessment
NS Ospina, NM Iñiguez-Ariza, MR Castro - bmj, 2020 - bmj.com
Thyroid nodules are extremely common and can be detected by sensitive imaging in more
than 60% of the general population. They are often identified in patients without symptoms …
than 60% of the general population. They are often identified in patients without symptoms …
Afirma gene sequencing classifier compared with gene expression classifier in indeterminate thyroid nodules
M Endo, F Nabhan, K Porter, K Roll, LA Shirley… - Thyroid, 2019 - liebertpub.com
Background: The Afirma Gene Expression Classifier (GEC) has been used to further
characterize cytologically indeterminate (cyto-I) thyroid nodules into either benign or …
characterize cytologically indeterminate (cyto-I) thyroid nodules into either benign or …
Core needle biopsy of the thyroid: 2016 consensus statement and recommendations from Korean Society of Thyroid Radiology
DG Na, JH Baek, SL Jung, J Kim… - Korean journal of …, 2017 - synapse.koreamed.org
Core needle biopsy (CNB) has been suggested as a complementary diagnostic method to
fine-needle aspiration in patients with thyroid nodules. Many recent CNB studies have …
fine-needle aspiration in patients with thyroid nodules. Many recent CNB studies have …
The Bethesda system for reporting thyroid cytopathology: proposed modifications and updates for the second edition from an international panel
Abstract The Bethesda System for Reporting Thyroid Cytology (TBSRTC) was proposed in
2007 at the National Cancer Institute Thyroid Fine Needle Aspiration State of the Art and …
2007 at the National Cancer Institute Thyroid Fine Needle Aspiration State of the Art and …
Evaluation of ThyroSeq v2 performance in thyroid nodules with indeterminate cytology
P Valderrabano, L Khazai, ME Leon… - Endocrine-related …, 2017 - erc.bioscientifica.com
Androgen receptor (AR), a steroid hormone receptor, is critical for prostate cancer growth.
However, activation of AR by androgens can also lead to growth suppression and …
However, activation of AR by androgens can also lead to growth suppression and …